__timestamp | Ionis Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
---|---|---|
Wednesday, January 1, 2014 | 241751000 | 1488000000 |
Thursday, January 1, 2015 | 322292000 | 1525000000 |
Friday, January 1, 2016 | 344320000 | 2111000000 |
Sunday, January 1, 2017 | 374644000 | 1848000000 |
Monday, January 1, 2018 | 414604000 | 1213000000 |
Tuesday, January 1, 2019 | 466000000 | 1010000000 |
Wednesday, January 1, 2020 | 535000000 | 997000000 |
Friday, January 1, 2021 | 643000000 | 967000000 |
Saturday, January 1, 2022 | 833000000 | 838000000 |
Sunday, January 1, 2023 | 899625000 | 953000000 |
Monday, January 1, 2024 | 901530000 | 998000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, Ionis Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited have been at the forefront of this race. From 2014 to 2023, Teva consistently outspent Ionis in research and development, with an average annual investment nearly 2.5 times higher. However, Ionis has shown remarkable growth, increasing its R&D spending by approximately 272% over this period. In 2023, Ionis reached a milestone, investing nearly 90% of Teva's R&D budget. This trend highlights Ionis's commitment to innovation, potentially reshaping the competitive landscape. As these companies continue to invest in groundbreaking research, the future of pharmaceuticals looks promising, with new treatments and technologies on the horizon.
Research and Development Investment: AstraZeneca PLC vs Teva Pharmaceutical Industries Limited
R&D Spending Showdown: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited vs Incyte Corporation: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited or Blueprint Medicines Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Alpine Immune Sciences, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Geron Corporation Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Evotec SE
Ionis Pharmaceuticals, Inc. vs Alkermes plc: Strategic Focus on R&D Spending
Ionis Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
R&D Insights: How Ionis Pharmaceuticals, Inc. and Wave Life Sciences Ltd. Allocate Funds
Ionis Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?